Cedric Rossi

18PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 12, 2026
Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

|Feb 26, 2026
Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.

Paul Marcoux, Fabien Gava, Marie Tosolini

|Oct 07, 2025
Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis.

Aurélie Montagne, Gildas Bertho, Thomas Papastergiou

|Jun 11, 2025
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.

Alexis Claudel, Anne-Ségolène Cottereau, Emmanuel Bachy

|May 06, 2025
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).

Katell Le Dû, Adrien Chauchet, Sophie Sadot-Lebouvier

|Mar 03, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.

Vincent Camus, Thierry Molina, Fabienne Desmots

Pageof 3

Frequent Collaborators

5 joint publications

Eric Durot

4 joint publications

Pierre Decazes

4 joint publications

Vincent Camus

4 joint publications

David Tonnelet